Tags

Type your tag names separated by a space and hit enter

[Post transfusionnal iron overload].
Rev Prat. 2006 Dec 15; 56(19):2141-5.RP

Abstract

Post transfusionnal iron overload is related to both a degree of RBC units transfused and excess intestinal absorption of Fe related to dyserythopoiesis. This condition is associated with high rates of morbidity and mortality, mainly of cardiac origin. Iron chelation therapy in patients with thalassemia who were effectively chelated has prevented or partially reversed some of these consequences. However the reference treatment by deferoxamine is strenuous and compliance is poor. Two oral iron chelators, deferiprone and deferasirox, provide potentially useful treatment for iron overload, both agents are relatively well tolerated (mainly deferasirox). They were at least as effective as DFO for decreasing iron burdens in comparative trials, and were associated with improved cardiac outcomes (for deferiprone). A new enthusiastic area for iron chelation with less burdensome treatments is open; however a long term follow up is required before giving up pumps and needles.

Authors+Show Affiliations

Service d'onco-hématologie, université catholique de Lille, hôpital Saint-Vincent-de-Paul, 59020 Lille Cedex. rose.christian@ghicl.net

Pub Type(s)

Comparative Study
Journal Article

Language

fre

PubMed ID

17416052

Citation

Rose, Christian. "[Post Transfusionnal Iron Overload]." La Revue Du Praticien, vol. 56, no. 19, 2006, pp. 2141-5.
Rose C. [Post transfusionnal iron overload]. Rev Prat. 2006;56(19):2141-5.
Rose, C. (2006). [Post transfusionnal iron overload]. La Revue Du Praticien, 56(19), 2141-5.
Rose C. [Post Transfusionnal Iron Overload]. Rev Prat. 2006 Dec 15;56(19):2141-5. PubMed PMID: 17416052.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Post transfusionnal iron overload]. A1 - Rose,Christian, PY - 2007/4/10/pubmed PY - 2007/4/28/medline PY - 2007/4/10/entrez SP - 2141 EP - 5 JF - La Revue du praticien JO - Rev Prat VL - 56 IS - 19 N2 - Post transfusionnal iron overload is related to both a degree of RBC units transfused and excess intestinal absorption of Fe related to dyserythopoiesis. This condition is associated with high rates of morbidity and mortality, mainly of cardiac origin. Iron chelation therapy in patients with thalassemia who were effectively chelated has prevented or partially reversed some of these consequences. However the reference treatment by deferoxamine is strenuous and compliance is poor. Two oral iron chelators, deferiprone and deferasirox, provide potentially useful treatment for iron overload, both agents are relatively well tolerated (mainly deferasirox). They were at least as effective as DFO for decreasing iron burdens in comparative trials, and were associated with improved cardiac outcomes (for deferiprone). A new enthusiastic area for iron chelation with less burdensome treatments is open; however a long term follow up is required before giving up pumps and needles. SN - 0035-2640 UR - https://www.unboundmedicine.com/medline/citation/17416052/[Post_transfusionnal_iron_overload]_ L2 - http://www.diseaseinfosearch.org/result/3874 DB - PRIME DP - Unbound Medicine ER -